Related references
Note: Only part of the references are listed.
Article
Critical Care Medicine
Miguel Angel Martinez-Garcia et al.
Summary: This study found a significant U-shaped relationship between BEC and severity and exacerbations in bronchiectasis, which was more prominent in the eosinopenic group. IC treatment only decreased the number and severity of exacerbations in the eosinophilic group.
Article
Critical Care Medicine
Amelia Shoemark et al.
Summary: Eosinophilic bronchiectasis is a common clinical entity that affects approximately 20% of patients. Blood eosinophil counts are associated with bronchiectasis severity, mortality, and time to exacerbation.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
(2022)
Article
Respiratory System
Helen K. Reddel et al.
Summary: The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an evidence-based strategy for asthma management and prevention, emphasizing the importance of regular personalized assessment, treatment of modifiable risk factors, self-management education, and appropriate medication adjustment for optimizing asthma outcomes.
ARCHIVOS DE BRONCONEUMOLOGIA
(2022)
Editorial Material
Respiratory System
Merete B. Long et al.
ARCHIVOS DE BRONCONEUMOLOGIA
(2022)
Editorial Material
Respiratory System
Borja G. Cosio et al.
ARCHIVOS DE BRONCONEUMOLOGIA
(2022)
Article
Respiratory System
Marc Miravitlles et al.
Summary: The Spanish COPD Guidelines (GesEPOC) provide evidence-based recommendations for the diagnosis and treatment of COPD, offering a more individualized approach tailored to the clinical characteristics and complexity level of patients.
ARCHIVOS DE BRONCONEUMOLOGIA
(2022)
Editorial Material
Respiratory System
Micheal Mac Aogain et al.
ARCHIVOS DE BRONCONEUMOLOGIA
(2022)
Article
Critical Care Medicine
Stefano Aliberti et al.
Summary: Bronchiectasis is a complex disease with multiple causes and diverse manifestations. Lack of standardized definitions has hindered clinical trials and poses challenges in clinical practice. In order to address these issues and improve patient recruitment and treatment comparisons, an international taskforce developed recommendations and definitions for clinically significant bronchiectasis. These proposals cover the radiological diagnosis of bronchiectasis and suggest guidelines for the use of chest CT scans in clinical trials. The taskforce also provided consensus statements on the definitions of clinical bronchiectasis, specific signs and symptoms, chronic bacterial infection, and sustained culture conversion. These recommendations aim to optimize the diagnosis and management of bronchiectasis and provide a foundation for future research.
LANCET RESPIRATORY MEDICINE
(2022)
Review
Pharmacology & Pharmacy
Miguel Angel Martinez-Garcia et al.
Summary: Inhaled corticosteroids are widely used in asthmatic patients and those with COPD, but their efficacy in non-cystic fibrosis bronchiectasis lacks scientific evidence. Bronchiectasis is characterized by neutrophilic inflammation, and the immunosuppressive properties of ICSs may increase bacterial infections.
